A novel vitamin D analog with two double bonds in its side chain A potent inducer of osteoblastic cell differentiation

Biochemical Pharmacology

Volumn 51, Issue 7, 1996, Pages 887-892

  Mahonen, Anitta ^a   Jääskeläinen, Tiina ^a   Mäenpää, Pekka H ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Alkaline phosphatase; Analog; Differentiation; Osteoblast; Osteocalcin; Vitamin D

Indexed keywords

1ALPHA,25 DIHYDROXY 22,24 DIENE 24,26,27 TRIHOMOVITAMIN D3; ALKALINE PHOSPHATASE; CALCITRIOL; MESSENGER RNA; OSTEOCALCIN; SEOCALCITOL; UNCLASSIFIED DRUG; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

ARTICLE; BIOSYNTHESIS; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; NORTHERN BLOTTING; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROMOTER REGION;

ANTINEOPLASTIC AGENTS; BASE SEQUENCE; CALCITRIOL; CELL DIFFERENTIATION; HUMANS; MOLECULAR SEQUENCE DATA; OSTEOSARCOMA; TIME FACTORS; TUMOR CELLS, CULTURED; VITAMIN D;

EID: 0029998720     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(95)02242-2     Document Type: Article

References (20)

1. 3 receptors: gene regulation and genetic circuitry. FASEB J 2: 3043-3053, 1988.
2. 3 metabolites. Cancer Res 43: 4443-4447, 1983.
3. 3: preferential activity in inducing differentiation of human-leukemia cells HL-60 in vitro. Proc Natl Acad Sci USA 84: 2610-2614, 1987.
4. Colston KW, MacKay AG, James SY, Binderup L, Chander S and Coombes RC, EB 1089: a new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro. Biochem Pharmacol 44: 2273-2280, 1992.
5. Mathiasen IS, Colston KW and Binderup L, EB 1089, a novel vitamin D analogue, has strong antiproliferative and differentiation inducing effects on cancer cells. J Steroid Biochem Molec Biol 46: 365-371, 1993.
6. Anderson CW, Lewis JB, Atkins JF and Gesteland RF, Cell-free synthesis of adenovirus 2 proteins programmed by fractioned messenger RNA: a comparison of polypeptide products and messenger RNA lengths. Proc Natl Acad Sci USA 71: 2750-2760, 1974.
7. Celeste AJ, Rosen V, Buecker JL, Kritz R, Wang EA and Wozney JM, Isolation of the human gene for bone gla protein utilizing mouse and rat cDNA clones. EMBO J 5: 1885-1890, 1986.
8. Enoch T, Zinn K and Maniatis T, Activation of the human β-interferon gene requires an interferon-inducible factor. Mol Cell Biol 6: 801-810, 1986.
9. Baker AR, McDonnell DP, Hughes MR, Crisp TM, Mangelsdorf DJ, Haussler MR, Pike JW, Shine J and O'Malley BW, Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA 85: 3294-3298, 1988.
10. Hurst HC, Masson N, Jones NC and Lee KA, The cellular transcription factor CREB corresponds to activating transcription factor 47 (ATF-47) and forms complexes with a group of polypeptides related to ATF-43. Mol Cell Biol 10: 6192-6203, 1990.
11. Schule R, Umesono K, Mangelsdorf DJ, Bolado J, Pike JW and Evans RM, Jun-Fos and receptors for vitamins A and D recognize a common response element in the human osteocalcin gene. Cell 61: 497-504, 1990.
12. Jääskeläinen T, Pirskanen A, Ryhänen S, Palvimo JJ, Deluca HF and Mäenpää PH, Functional interference between AP-1 and the vitamin D receptor on osteocalcin gene expression in human osteosarcoma cells. Eur J Biochem 224: 11-20, 1994.
13. Bouillon R, Okamura WH and Norman AW, Structure-function relationships in the vitamin D endocrine system. Endocrine Rev 16: 200-257, 1995.
14. 3 analogues with potent effects on cell growth regulation and immune responses: structure-activity studies. In Vitamin D: Gene Regulation, Structure-Function Analysis and Clinical Applications: Proceedings of the 8th Workshop on Vitamin D (Eds. Norman AW, Bouillon R and Thomasset M), de Gruyter, Berlin, pp. 478-485, 1991.
15. 3. Endocrinology 136: 20-26, 1995.
16. 3 on its receptor mRNA levels and osteocalcin synthesis in human osteosarcoma cells. Biochim Biophys Acta 1048: 30-37, 1990.
17. Mahonen A and Mäenpää PH, Steroid hormone modulation of vitamin D receptor levels in human MG-63 osteosarcoma cells. Biochem Biophys Res Commun 205: 1179-1186, 1994.
18. 3 (VD) analogues MC903, EB1089 and KH1060 activate the VD receptor: homodimers show higher ligand sensitivity than heterodimers with retinoid X receptors. J Steroid Biochem Mol Biol 51: 137-142, 1994.
19. Mathiasen IS, Mackay AG, Colston KW and Binderup L, EB 1089, a vitamin D analogue, induces the vitamin D receptor to form selective receptor complexes depending on cell type. In: Vitamin D: A Pluripotent Steroid Hormone: Structural Studies, Molecular Endocrinology and Clinical Applications: Proceedings of the 9th Workshop on Vitamin D (Eds. Norman AW, Bouillon R and Thomasset M), de Gruyter, Berlin, pp. 255-256, 1994.
20. 3 are associated with enhanced activation of the vitamin D receptor. J Biol Chem 270: 10551-10568, 1995.